Title

Ibrutinib and rituximab provides superior clinical outcome compared to FCR in younger patients with chronic lymphocytic leukemia (CLL): Extended follow-up from the E1912 trial

Affiliations

Aurora Cancer Care

Document Type

Article

PubMed ID

31723996

DOI

10.1182/blood-2019-126824

Link to Full Text

Share

COinS